Ratings Great-West Lifeco Inc.

Equities

GWO

CA39138C1068

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
40.45 ^CAD	+0.65%		+0.47%	-7.77%

Apr. 26	National Bank Previews Lifecos' Q1, Cuts IAG Q1 Forecast by 5%	MT
Apr. 22	Great-West Lifeco Inc.(TSX:GWO.PRT) dropped from S&P/TSX Preferred Share Index	CI

Strengths

Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 73% by 2026.
With a P/E ratio at 9.86 for the current year and 9.21 for next year, earnings multiples are highly attractive compared with competitors.
The company is one of the best yield companies with high dividend expectations.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
GREAT-WEST LIFECO INC.	-7.77%	27.56B	B-
AXA	+14.78%	79.51B	B-
METLIFE, INC.	+6.49%	50.22B	B+
AFLAC INCORPORATED	+1.35%	48.11B	B
PRUDENTIAL FINANCIAL, INC.	+6.55%	39.71B	B+
GENERALI	+19.34%	37.78B	B
SUN LIFE FINANCIAL INC.	+2.84%	30.07B	B
PRUDENTIAL PLC	-18.42%	24.71B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+6.89%	21.99B	A
DAI-ICHI LIFE HOLDINGS, INC.	+20.69%	21.68B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes